Interpretation of data in the continuous monitoring of glucose. Recommendations for the indication

Authors

  • Gabriela Rovira British Hospital of Buenos Aires, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v53i2Sup.234

Keywords:

diabetes, monitoring

Abstract

Glycemic monitoring is a fundamental pillar in the treatment of the patient with diabetes. Epidemiological studies such as the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT / EDIC) demonstrated that to improve the degree of metabolic control in patients with type 1 diabetes mellitus (DM1) through intensive treatment With any of the insulin therapy modalities (MDI, multiple doses of subcutaneous insulin; ISCI, continuous subcutaneous insulin infusion) frequent measurements of capillary blood glucose daily are required and this information must be used to effect changes in the treatment.

Author Biography

Gabriela Rovira, British Hospital of Buenos Aires, Autonomous City of Buenos Aires, Argentina

Coordinator of the Diabetes and Pregnancy Committee of the Argentine Diabetes Society (SAD); Medical Endocrinologist at the British Hospital of Buenos Aires

References

- Canadian Diabetes Association 2013. Clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2013; 37 (suppl 1):S1-S212.

- Bolinder J. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet 2016; 6736(16):1-10.)

- Danne T. International Consensus on use of continuous glucose monitoring. Diabetes Care 2017; 40:1631-1640.

- American Diabetes Association. Standards of medical care. Diabetes Technology. Diabetes Care 2019; 42(Suppl.1):S1-S.

Downloads

Published

2023-01-10

How to Cite

Rovira, G. (2023). Interpretation of data in the continuous monitoring of glucose. Recommendations for the indication. Journal of the Argentine Society of Diabetes, 53(2Sup), 20. https://doi.org/10.47196/diab.v53i2Sup.234

Issue

Vol. 53 No. 2Sup (2019): May/Agost 2019

Section

Conferences and congresses

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)